Moleculin Biotech MBRX Stock
Moleculin Biotech Price Chart
Moleculin Biotech MBRX Financial and Trading Overview
| Moleculin Biotech stock price | 0.61 USD |
| Previous Close | 0.59 USD |
| Open | 0.59 USD |
| Bid | 0.58 USD x 100 |
| Ask | 0.77 USD x 200 |
| Day's Range | 0.56 - 0.63 USD |
| 52 Week Range | 0.16 - 15.75 USD |
| Volume | 287.82K USD |
| Avg. Volume | 1.22M USD |
| Market Cap | 11.55M USD |
| Beta (5Y Monthly) | 1.828 |
| PE Ratio (TTM) | 0.04006757 |
| EPS (TTM) | 15.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 18.33 USD |
MBRX Valuation Measures
| Enterprise Value | 4.58M USD |
| Trailing P/E | 0.04006757 |
| Forward P/E | -0.005366516 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.36335784 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.159 |
Trading Information
Moleculin Biotech Stock Price History
| Beta (5Y Monthly) | 1.828 |
| 52-Week Change | -95.87% |
| S&P500 52-Week Change | 18.67% |
| 52 Week High | 15.75 USD |
| 52 Week Low | 0.16 USD |
| 50-Day Moving Average | 1.83 USD |
| 200-Day Moving Average | 3.58 USD |
MBRX Share Statistics
| Avg. Volume (3 month) | 1.22M USD |
| Avg. Daily Volume (10-Days) | 1.03M USD |
| Shares Outstanding | 19.48M |
| Float | 10.56M |
| Short Ratio | 1.27 |
| % Held by Insiders | 6.41% |
| % Held by Institutions | 8.56% |
| Shares Short | 1.58M |
| Short % of Float | 22.35% |
| Short % of Shares Outstanding | 22.20% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -84.56% |
| Return on Equity (ttm) | -1371.64% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -28828000 USD |
| Net Income Avi to Common (ttm) | -32525000 USD |
| Diluted EPS (ttm) | 14.8 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.26M USD |
| Total Cash Per Share (mrq) | 0.37 USD |
| Total Debt (mrq) | 292K USD |
| Total Debt/Equity (mrq) | 2.52 USD |
| Current Ratio (mrq) | 0.937 |
| Book Value Per Share (mrq) | 1.632 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -25357000 USD |
| Levered Free Cash Flow (ttm) | -14919750 USD |
Profile of Moleculin Biotech
| Country | United States |
| State | TX |
| City | Houston |
| Address | 5300 Memorial Drive |
| ZIP | 77007 |
| Phone | 713 300 5160 |
| Website | https://moleculin.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 17 |
Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses. Its lead drug candidate is Annamycin, an anthracycline, which is in clinical stage for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung metastases. The company is also developing WP1066 portfolio, including WP1066, WP1193, and WP1220, which are immune/transcription modulators designed to inhibit phosphorylated signal transducer and activator of transcription for brain tumors and pancreatic and other cancers. In addition, it is developing WP1122 portfolio, such as WP1122, WP1096, and WP1097 designed to exploit the uses of inhibitors of glycolysis comprising 2-deoxy-D-glucose that cut off the energy supply of tumors. The company was incorporated in 2015 and is headquartered in Houston, Texas.
Q&A For Moleculin Biotech Stock
What is a current MBRX stock price?
Moleculin Biotech MBRX stock price today per share is 0.61 USD.
How to purchase Moleculin Biotech stock?
You can buy MBRX shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Moleculin Biotech?
The stock symbol or ticker of Moleculin Biotech is MBRX.
Which industry does the Moleculin Biotech company belong to?
The Moleculin Biotech industry is Biotechnology.
How many shares does Moleculin Biotech have in circulation?
The max supply of Moleculin Biotech shares is 19.48M.
What is Moleculin Biotech Price to Earnings Ratio (PE Ratio)?
Moleculin Biotech PE Ratio is 0.04059294 now.
What was Moleculin Biotech earnings per share over the trailing 12 months (TTM)?
Moleculin Biotech EPS is 15.01 USD over the trailing 12 months.
Which sector does the Moleculin Biotech company belong to?
The Moleculin Biotech sector is Healthcare.
Moleculin Biotech MBRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25980.19 USD — |
-0.77
|
6.45B USD — | 25910.82 USD — | 26109.96 USD — | — - | 6.45B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
142.54 USD — |
-1.15
|
— — | 141.96 USD — | 143.5 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1361.34 USD — |
-0.47
|
— — | 1351.98 USD — | 1363.95 USD — | — - | — — |
- {{ link.label }} {{link}}
